Espuña Pons M, Cassadó J, Díez Itza I, Valero Fernández E M
Unidad de Uroginecología, ICGON, Hospital Clínic de Barcelona, Barcelona, España.
Hospital Universitari Mutua Terrassa, Terrassa, España.
Actas Urol Esp (Engl Ed). 2021 Jan-Feb;45(1):57-63. doi: 10.1016/j.acuro.2020.03.004. Epub 2020 Jun 24.
The present study evaluates the impact of vaginal surgery for pelvic organ prolapse (POP) on voiding dysfunction (VD) symptoms and post-void residual (PVR) one year after the intervention.
Epidemiological, longitudinal, prospective study. Thirty-nine gynecology units included women with symptomatic POP grade 2 or higher according to the Pelvic Organ Prolapse Quantification (POP-Q) system, who would undergo surgery for vaginal prolapse (CIRPOP-IUE study). Sociodemographic and clinical variables were collected before and after the intervention. At both visits, patients completed the 'Epidemiology of Prolapse and Incontinence Questionnaire' (EPIQ) and 'Pelvic Floor Distress Inventory' (PFDI-20) questionnaire. PVR volume was measured by bladder catheterization immediately after spontaneous urination.
VD symptoms were present in 50% cases before the intervention. PVR was measured in 277 women of which 116 (41.87%) were >50ml and 42/277 (15.2%) were >100ml. Objective and subjective reduction in VD symptoms was observed one year after the intervention. Mean PVR volume was reduced with statistical significance, from a mean (SD) of 66.4 (68.9)ml to 48.3 (51.3)ml. The number of patients who reported difficulty in emptying and sensation of incomplete emptying on the EPIQ and PFDI-20 questionnaires also decreased.
In general, improved voiding functions were observed in the CIRPOP-IUE study through a decrease in specific VD symptoms and a reduction in mean PVR volume.
本研究评估盆腔器官脱垂(POP)阴道手术对干预后一年排尿功能障碍(VD)症状及残余尿量(PVR)的影响。
流行病学、纵向、前瞻性研究。39个妇科单位纳入了根据盆腔器官脱垂定量(POP-Q)系统诊断为2级或更高分级的有症状POP且将接受阴道脱垂手术的女性(CIRPOP-IUE研究)。在干预前后收集社会人口统计学和临床变量。在两次就诊时,患者均完成“脱垂与尿失禁流行病学问卷”(EPIQ)和“盆底困扰量表”(PFDI-20)问卷。在自然排尿后立即通过膀胱插管测量残余尿量。
干预前50%的病例存在VD症状。对277名女性测量了残余尿量,其中116名(41.87%)残余尿量>50ml,42/277名(15.2%)残余尿量>100ml。干预一年后观察到VD症状在客观和主观上均有所减轻。平均残余尿量有统计学意义地减少,从平均(标准差)66.4(68.9)ml降至48.3(51.3)ml。在EPIQ和PFDI-20问卷中报告排尿困难和排尿不尽感的患者数量也减少了。
总体而言,在CIRPOP-IUE研究中观察到排尿功能有所改善,具体表现为特定VD症状减少以及平均残余尿量降低。